Anti-dsDNA Abs, the hallmark antibodies of SLE, can trigger NLRP3 inflammasome activation in monocytes/macrophages in patients with SLE by inducing mitochondrial ROS production and activating the TLR4-NF-κB signal pathway (106). Here, NFKB1 is linked to systemic lupus erythematosus.